Eric Keller reports a stock award at RTSN

By AlphaYouPublished Oct 22, 2026Form 4

Stocks in this disclosure

Reported activity

Keller Eric L.

Reporting filer

Eric Keller reports a stock award, not an open-market purchase or sale, in Retension Pharmaceuticals, Inc.. Form 4 filed Oct 22, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Option (right to buy) (derivative)	Keller Eric L.	2026-10-22	A	Grant or award	40884	0	40,884	0 days	Filed terms security Title: Stock Option (right to buy) id: F1 conversion Or Exercise Price: 15.50 transaction Date: 2026-10-22 deemed Execution Date: transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Timeliness: transaction Shares: 40884 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-10-22 underlying Security Title: Common Stock underlying Security Shares: 40884 shares Owned Following Transaction: 40884 direct Or Indirect Ownership: D

Owner: Keller Eric L.
Date: 2026-10-22
Code: A
Action: Grant or award
Quantity: 40884
Price: 0
Following holdings: 40,884
Reporting delay: 0 days
Filed terms and references: Filed terms
security Title: Stock Option (right to buy)
id: F1
conversion Or Exercise Price: 15.50
transaction Date: 2026-10-22
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 40884
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-10-22
underlying Security Title: Common Stock
underlying Security Shares: 40884
shares Owned Following Transaction: 40884
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Keller Eric L.: CHIEF EXECUTIVE OFFICER, Director.
F1: Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. The option award was granted as a result of the underwriters' exercise of their over-allotment option on October 22, 2026 in connection with the Issuer's initial public offering, pursuant to the terms of the Reporting Person's Offer of Employment Letter with the Issuer, dated August 14, 2026. Twenty-five percent of the stock option vests on August 14, 2027, with the remaining stock options vesting in 36 monthly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Prepared automatically from public filing data. Report a correction.